Advancing RNA

ARW ON RNA

Can Oligonucleotide Regulations Keep Up With Manufacturing Innovation?

Here in part 2 of my TIDES takeaways, I’ll unpack which guidances we have at our disposal today in the oligo world, and what we can expect in the future.

OUR EXPERT NETWORK

How Targeted Nanoparticles And Circular RNA Are Advancing CAR-T Development
To overcome the short duration of therapeutic protein expression associated with mRNA, Sail Biomedicine has developed novel endless RNA constructs. Michael Lam, Ph.D., discusses its delivery mechanisms and an outlook for future applications.
The Future Of RNA Manufacturing: Continuous Processing, AI, And Distributed Production (Pt. 3)
Continuous manufacturing, AI, modular facilities, and next-generation RNA platforms are reshaping how therapies are produced, scaled, and delivered worldwide.
Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
While circular RNA platforms can enhance protein expression, developing effective delivery strategies remains the key challenge to achieving therapeutic efficacy.
Unlocking The Future Of mRNA
Many regulatory frameworks and analytical approaches were not originally designed for platforms like mRNA. Addressing these gaps will be essential to fully realize the potential of mRNA technologies.
The Missing Partners In microRNA Silencing: What QKI Reveals About RNA Regulatory Complexity
New research suggests microRNA silencing depends on RNA-binding protein partners like QKI, revealing a more complex regulatory network shaping gene expression.

WEBINARS

Automating cell therapy manufacturing without redesigning established workflow

Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors

Unlocking The Next Wave Of Cancer Vaccines

Imagine The Future: An Enhanced Oligonucleotide Synthesis Process

Your AKTA Oligosynt™ System : It's More Than A Machine

Take The Wheel And Drive Your Oligo Synthesis Where You Want

Five Practical Considerations To Move From Concept To Clinic

Hear From The Experts: LNPs Driving The Future Of Cell Therapy

MEET ARW

I’ve spent the past 10 years building relationships across the biologics and advanced therapies industry. In addition to hosting conversations and writing thought leadership articles, my goal as the editorial and community director for Advancing RNA is to find creative ways for the RNA (and broader ATMP) space to discuss, debate, and ultimately define a mature RNA therapeutics industry.

Start the conversation by following me on LinkedIn!

RNA HOT TAKES

VIRTUAL EVENTS

More Virtual Events

NEWSLETTER ARCHIVE

More Newsletters